Related references
Note: Only part of the references are listed.Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells
Changhwan Yoon et al.
CLINICAL CANCER RESEARCH (2016)
Predictors of outcome after surgery for gastric cancer in a Western cohort
Sharon Pattison et al.
ANZ JOURNAL OF SURGERY (2016)
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
Se Hoon Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani et al.
LANCET (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
Miwako Kakiuchi et al.
NATURE GENETICS (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang et al.
NATURE GENETICS (2014)
Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China
Miao-zhen Qiu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach
Alessandro Bittoni et al.
PLOS ONE (2013)
Three decades of clinical-pathological trends in gastric cancer: Prospective data from a Portuguese hospital
Gil R. Faria et al.
INTERNATIONAL JOURNAL OF SURGERY (2013)
Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
Stephen R. Smalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Changing clinical and pathological features of gastric cancer over time
D. Marrelli et al.
BRITISH JOURNAL OF SURGERY (2011)
Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
Iain Beehuat Tan et al.
GASTROENTEROLOGY (2011)
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
Narikazu Boku et al.
LANCET ONCOLOGY (2009)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
